Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ICLR

Icon Plc

Jul 26 • 04:00PM ET

323.46

Dollar change +10.36
Percentage change 3.31	%

Healthcare • Diagnostics & Research • Ireland • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: EIRL SPDW BBH TMFG VT DSTL QQQJ DFAC ONEQ ESGV

Scroll to Statements

Index	-	P/E	37.65	EPS (ttm)	8.59	Insider Own	0.92%	Shs Outstand	82.50M	Perf Week	-1.89%
Market Cap	26.74B	Forward P/E	18.73	EPS next Y	17.27	Insider Trans	0.00%	Shs Float	81.92M	Perf Month	3.35%
Income	714.43M	PEG	2.45	EPS next Q	3.86	Inst Own	96.80%	Short Float	1.80%	Perf Quarter	7.79%
Sales	8.33B	P/S	3.21	EPS this Y	17.96%	Inst Trans	0.87%	Short Ratio	2.45	Perf Half Y	21.84%
Book/sh	115.74	P/B	2.79	EPS next Y	14.47%	ROA	4.19%	Short Interest	1.47M	Perf Year	27.80%
Cash/sh	6.13	P/C	52.80	EPS next 5Y	15.37%	ROE	7.77%	52W Range	221.20 - 347.72	Perf YTD	14.27%
Dividend Est.	-	P/FCF	22.81	EPS past 5Y	4.42%	ROI	5.44%	52W High	-6.98%	Beta	1.22
Dividend TTM	-	Quick Ratio	1.31	Sales past 5Y	29.97%	Gross Margin	22.53%	52W Low	46.23%	ATR (14)	10.95
Dividend Ex-Date	-	Current Ratio	1.31	EPS Y/Y TTM	38.89%	Oper. Margin	13.50%	RSI (14)	48.34	Volatility	5.35% 2.99%
Employees	41100	Debt/Eq	0.37	Sales Y/Y TTM	5.42%	Profit Margin	8.57%	Recom	1.50	Target Price	367.80
Option/Short	Yes / Yes	LT Debt/Eq	0.37	EPS Q/Q	25.97%	Payout	0.00%	Rel Volume	1.51	Prev Close	313.10
Sales Surprise	-0.79%	EPS Surprise	1.84%	Sales Q/Q	4.95%	Earnings	Jul 24 AMC	Avg Volume	601.75K	Price	323.46
SMA20	-1.08%	SMA50	0.48%	SMA200	10.14%	Trades		Volume	908,585	Change	3.31%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-06-24	Initiated	Goldman	Buy	$370
Dec-15-23	Initiated	Truist	Buy	$357
Sep-13-23	Initiated	TD Cowen	Outperform	$306
Jan-17-23	Upgrade	Barclays	Equal Weight → Overweight	$215 → $260
Jan-13-23	Upgrade	Barclays	Equal Weight → Overweight
Nov-09-22	Upgrade	BofA Securities	Neutral → Buy	$265 → $260
Sep-07-22	Initiated	UBS	Buy	$270
Aug-25-22	Initiated	Credit Suisse	Neutral	$260
May-24-22	Initiated	Guggenheim	Buy	$285
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$250
Apr-12-22	Upgrade	Deutsche Bank	Hold → Buy	$234 → $310
Sep-27-21	Upgrade	JP Morgan	Neutral → Overweight	$230 → $320
Aug-05-21	Resumed	Credit Suisse	Outperform	$250
Jul-23-21	Upgrade	Citigroup	Neutral → Buy	$260
Jul-14-21	Initiated	Citigroup	Neutral	$220
Apr-13-21	Resumed	BofA Securities	Neutral	$220
Apr-01-21	Upgrade	Wells Fargo	Equal Weight → Overweight	$200 → $235
Mar-08-21	Upgrade	Robert W. Baird	Neutral → Outperform	$215
Mar-03-21	Initiated	Barclays	Equal Weight	$200
Mar-01-21	Upgrade	UBS	Neutral → Buy	$207 → $232

Show Previous Ratings

Today 09:09AM	ICON (ICLR) Q2 Earnings Surpass Estimates, Margins Expand (Zacks)
Jul-25-24 01:22PM	Analyst Report: ICON Public Limited Company (Morningstar Research) -5.63%
Jul-24-24 09:53PM	ICLR Stock Earnings: Icon Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
06:10PM	Icon PLC (ICLR) Q2 Earnings Surpass Estimates (Zacks)
04:15PM	ICON Reports Second Quarter 2024 Results (Business Wire)
06:00AM	Loading…
06:00AM	ICON announces results of Annual General Meeting and changes to the Board of Directors (Business Wire)
Jul-22-24 09:45AM	Why Icon PLC (ICLR) is a Top Growth Stock for the Long-Term (Zacks)
Jul-18-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Icon PLC (ICLR) (Zacks)
09:50AM	Why Icon PLC (ICLR) is a Top Momentum Stock for the Long-Term (Zacks)
Jul-10-24 09:40AM	Here's Why Icon PLC (ICLR) is a Strong Value Stock (Zacks)
07:15AM	ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer (Business Wire)
Jul-08-24 12:33PM	Icon PLC (ICLR) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Jul-01-24 04:15PM	ICON plc Schedules Second Quarter 2024 Earnings Conference Call (Business Wire)
Jun-28-24 12:45PM	Is Icon PLC (ICLR) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Jun-24-24 09:40AM	Why Icon PLC (ICLR) is a Top Value Stock for the Long-Term (Zacks)
09:50AM	Loading…
Jun-20-24 09:50AM	Here's Why Icon PLC (ICLR) is a Strong Momentum Stock (Zacks)
Jun-19-24 09:45AM	Why Icon PLC (ICLR) is a Top Growth Stock for the Long-Term (Zacks)
Jun-05-24 12:45PM	Icon PLC (ICLR) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
12:00PM	Icon PLC (ICLR) Upgraded to Buy: Here's What You Should Know (Zacks)
Jun-04-24 09:50AM	Why Icon PLC (ICLR) is a Top Momentum Stock for the Long-Term (Zacks)
06:00AM	ICON plc to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-31-24 04:09AM	Icon PLC (ICLR) Soars 4.3%: Is Further Upside Left in the Stock? (Zacks)
May-30-24 09:55AM	Do Options Traders Know Something About ICON (ICLR) Stock We Don't? (Zacks)
08:00AM	ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance (Business Wire)
May-28-24 08:44AM	Here's Why Investors Should Retain ICON (ICLR) Stock Now (Zacks)
May-24-24 11:31AM	Icon PLC (ICLR) Up 6.6% Since Last Earnings Report: Can It Continue? (Zacks)
May-20-24 06:00AM	ICON plc to hold Investor Day Meeting on May 30, 2024 (Business Wire)
May-09-24 06:30AM	ICON releases its ICON Cares 2023 Report (Business Wire)
Apr-30-24 04:55PM	ICON Announces Pricing of USD 2 Billion Notes (Business Wire)
02:52PM	ICON Public Limited Company (NASDAQ:ICLR) Q1 2024 Earnings Call Transcript (Insider Monkey)
09:45AM	Loading…
09:45AM	Icon PLC (ICLR) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Apr-26-24 08:16AM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Apr-25-24 01:43PM	ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand (Zacks)
Apr-24-24 05:55PM	Icon PLC (ICLR) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:15PM	ICON Reports First Quarter 2024 Results (Business Wire)
08:54AM	Reason for the Surge of ICON Public Limited Company (ICLR) (Insider Monkey)
Apr-18-24 10:40AM	ICON (ICLR) Gains From New Offerings, Strategic Acquisitions (Zacks)
Apr-17-24 10:01AM	Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-03-24 04:15PM	ICON Announces CFO Transition (Business Wire)
Apr-01-24 08:50AM	Recent Price Trend in Icon PLC (ICLR) is Your Friend, Here's Why (Zacks)
Mar-29-24 02:30AM	ICON Public Limited Company (ICLR) Improved by 15% in Q4 (Insider Monkey)
Mar-25-24 04:15PM	ICON plc Schedules First Quarter 2024 Earnings Conference Call (Business Wire)
Mar-22-24 11:30AM	ICON (ICLR) Up 7.6% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-15-24 08:50AM	Icon PLC (ICLR) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Mar-04-24 11:26AM	ICON (ICLR) Gains From Strategic Deals, New Innovations (Zacks)
Feb-29-24 12:00PM	Are You Looking for a Top Momentum Pick? Why Icon PLC (ICLR) is a Great Choice (Zacks)
Feb-28-24 12:00PM	All You Need to Know About Icon PLC (ICLR) Rating Upgrade to Buy (Zacks)
08:50AM	Here's Why Momentum in Icon PLC (ICLR) Should Keep going (Zacks)
Feb-26-24 04:15PM	ICON plc to Present at Upcoming Investor Conferences (Business Wire)
12:25PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Feb-23-24 09:00AM	ICON Public Limited Company (NASDAQ:ICLR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-22-24 04:35PM	ICON (ICLR) Q4 Earnings Surpass Estimates, Margins Expand (Zacks) +10.07%
Feb-21-24 06:30PM	Icon PLC (ICLR) Q4 Earnings Surpass Estimates (Zacks)
04:15PM	ICON Reports Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-09-24 10:18PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Jan-30-24 06:00AM	ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call (Business Wire)
Jan-24-24 07:00AM	New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment (Business Wire)
Jan-10-24 06:30PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Jan-09-24 08:00AM	ICON Issues Financial Guidance for Full Year 2024 (Business Wire)
Jan-08-24 07:00AM	Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON (Business Wire)
Jan-04-24 07:00AM	ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-18-23 07:15AM	ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023 (Business Wire)
Dec-11-23 06:41PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Dec-08-23 06:00AM	Reasons to Invest in ICON (ICLR) (Insider Monkey)
Dec-07-23 04:15PM	ICON Secures Upgraded Credit Rating from Moodys Investors Service (Business Wire)
Nov-20-23 12:45PM	3 Reasons Growth Investors Will Love Icon PLC (ICLR) (Zacks)
Nov-13-23 09:02PM	Apple Demos More Vision Pro Spatial Videos, 3D Movie Icon Appears on Apple TV, Humane Ai Pin vs. Spatial Photos/Videos (Above Avalon)
Nov-08-23 06:00AM	ICON plc to Present at Upcoming Investor Conferences (Business Wire)
Nov-06-23 12:27PM	Is it Still Worthy to Invest in ICON Public Limited (ICLR)? (Insider Monkey)
Nov-01-23 12:45PM	Here is Why Growth Investors Should Buy Icon PLC (ICLR) Now (Zacks)
Oct-30-23 01:06PM	Hedge Fund and Insider Trading News: Joseph Edelman, Ken Griffin, Seth Klarman, Two Sigma Advisors, Sculptor Capital Management, Aligos Therapeutics Inc (ALGS), The Progressive Corporation (PGR), and More (Insider Monkey)
Oct-27-23 03:29PM	ICON Public Limited Company (NASDAQ:ICLR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 03:29PM	Analyst Report: ICON Public Limited Company (Morningstar Research) +6.78%
Oct-25-23 06:30PM	Icon PLC (ICLR) Beats Q3 Earnings and Revenue Estimates (Zacks)
04:15PM	ICON Reports Third Quarter 2023 Results (Business Wire)
Oct-23-23 10:00AM	Analysts Estimate Revvity (RVTY) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-12-23 09:07AM	ICON Secures Upgraded Credit Rating from S&P Global Ratings (Business Wire)
Oct-02-23 08:17PM	Taco Bell's Sean Tresvant: 'If we're not uncomfortable, we're not pushing hard enough' (Nation's Restaurant News)
Sep-28-23 05:00PM	3 Publicly Traded Companies Most at Risk of an AI Smackdown (InvestorPlace)
Sep-21-23 11:40AM	ICLR vs. GDRX: Which Stock Is the Better Value Option? (Zacks)
06:00AM	ICON plc Schedules Third Quarter 2023 Earnings Conference Call (Business Wire)
Sep-20-23 07:15AM	ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution (Business Wire)
Sep-18-23 06:20AM	Reasons for the Outperformance of ICON Public Limited Company (ICLR) (Insider Monkey)
Sep-13-23 07:31AM	ICON to partner with US govt agency to test COVID-19 vaccine candidates (Reuters)
07:15AM	BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial (Business Wire)
Sep-06-23 06:00AM	ICON plc to Present at the Baird Global Healthcare Conference (Business Wire)
Sep-05-23 11:40AM	ICLR vs. GDRX: Which Stock Should Value Investors Buy Now? (Zacks)
Aug-18-23 11:40AM	ICLR or GDRX: Which Is the Better Value Stock Right Now? (Zacks)
Aug-17-23 08:39AM	Heres Why ICON Public Limited Company (ICLR) Outperformed in Q2 (Insider Monkey)
Jul-29-23 08:03AM	Is Now The Time To Put ICON (NASDAQ:ICLR) On Your Watchlist? (Simply Wall St.)
Jul-28-23 02:19PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Jul-26-23 06:55PM	Icon PLC (ICLR) Surpasses Q2 Earnings Estimates (Zacks)
04:20PM	ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting (Business Wire)
04:15PM	ICON Reports Second Quarter 2023 Results (Business Wire)
Jul-20-23 11:40AM	ICLR or GDRX: Which Is the Better Value Stock Right Now? (Zacks)
Jul-19-23 10:01AM	Icon PLC (ICLR) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-13-23 07:15AM	First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital Services (Business Wire)
Jul-03-23 09:54AM	Should You Investigate ICON Public Limited Company (NASDAQ:ICLR) At US$250? (Simply Wall St.)
Jun-27-23 04:15PM	ICON plc Schedules Second Quarter 2023 Earnings Conference Call (Business Wire)
Jun-26-23 07:15AM	ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform (Business Wire)

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICLR

Icon Plc

Upgrade your FINVIZ experience